Magnesium oxide
As of the edition of 20 October 2026, Magnesium oxide is a small molecule: marketed, first approved in 1982 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2026
- Kind
- Small molecule
- Brand name
- Irrigating Solution G In Plastic Container
- First approved
- 22 June 1982 (US)
- Approvals on record
- 8 in 4 regions
- Holder of the most recent approval
- Leman SKL SA; 5 holders in all
- Registered trials
- 20, 0 stopped early
- Disease areas
- Cancer; Digestive system; Heart and blood vessels; Injuries; Skin and connective tissue; Infections
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 7 | 4 | 0 | 0 |
| Phase 1 | 2 | 1 | 1 | 0 |
| Phase 2 | 3 | 2 | 1 | 0 |
| Phase 3 | 3 | 3 | 0 | 0 |
| Phase 4 | 5 | 2 | 1 | 0 |
| All trials | 20 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Ferring Pharmaceuticals | Applicant and Lead sponsor of trials | 2004 to now |